Bonaventura Clotet Sala

10PUBLICATIONS
79CO-AUTHORS
Innate immunityInfectious diseasesPacific Peoples and disabilityMedical molecular engineering of nucleic acids and proteinsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 25, 2025
Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamsters.

Núria Pedreño-López, Ferran Tarrés-Freixas, Carla Usai

|Jun 27, 2025
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 Reinfections.

Francisco Muñoz-López, Antoni E Bordoy, Francesc Català-Moll

|Feb 24, 2025
Plasma exchange therapy for the post COVID-19 condition: a phase II, double-blind, placebo-controlled, randomized trial.

Sergio España-Cueto, Cora Loste, Gemma Lladós

|Feb 07, 2025
Targeting eEF1A reprograms translation and uncovers broad-spectrum antivirals against cap or m6A protein synthesis routes.

Elisa Molina Molina, Joan Josep Bech-Serra, Eloi Franco-Trepat

|Mar 22, 2024
Immunization with V987H-stabilized Spike glycoprotein protects K18-hACE2 mice and golden Syrian hamsters upon SARS-CoV-2 infection.

Carlos Ávila-Nieto, Júlia Vergara-Alert, Pep Amengual-Rigo

|Feb 23, 2023
Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines.

Carmen Aguilar-Gurrieri, Ana Barajas, Carla Rovirosa

Pageof 2